AKAN
AKANDA (AKAN)
NASDAQ
$1.25+$0.10 (+8.70%)
Price as of Oct 22, 2026 7:59 PM EDT
  • $2.7M
    Market Cap
  • -97.77%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 56
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$1.09
$1.33
$1.15
1-Year Range
$0.45
$57.09
$1.15
Latest Close$1.15
Change
+$0.03 (+2.61%)
Volume3,089,050
Market Cap$2.7M
Shares Outstanding2.4M
P/E (TTM)-0.00008
Diluted EPS (TTM)-$14,899.95
Enterprise Value$3.3M

Information as of 10/22/2026

Company Profile

$2.7M
Market Cap
-$45.7M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
100 King St. W, Toronto, ON, Canada, M5X 1G5
416 862 7525

Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.

Key Executives

  • Christopher Robert Cooper
  • Katharyn Field
  • Edgar Contreras
  • Gurcharn Deol
  • Francisco Juarez

Current Ownership Distribution

  • Other957,709 (40.10%)
  • Mutual Funds725,529 (30.38%)
  • Institutions697,158 (29.19%)
  • Insiders7,816 (0.33%)